1. Introduction {#sec1}
===============

Corona Virus Disease 2019 (COVID-19), which is caused by a newly identified coronavirus SARS-COV-2, has been spread to more than 200 countries and regions around the world and posing significant threats to public health ([@bib2]). Unfortunately, it is still raging with no effective drugs clinically approved. Given the severity of SARS-COV-2, it is critical to discovery and clinical application of specific drugs against SARS-COV-2 to alleviate the current epidemic situation. It is particularly important to screen possible blockers for the potential target proteins of virus by computational chemical biology techniques such as molecular docking ("dry method"research) in special cases such as the outbreak of SARS-COV-2 ([@bib12]). This approach conducive to large-scale screening in a short period of time. It has been recommended two main proteins, 3C-like protease (3CLpro) and angiotensin-converting enzyme 2 (ACE2), could be used as available targets for screening drugs that inhibiting the replication and proliferation of SARS-COV-2, benefit from rapid sequencing of SARS-COV-2 coupled with molecular modelling based on the genomes of related viral proteins ([@bib3]; [@bib1]).

Chinese Medicines (CMs), a long history system of medicine with distinct features of theories and practices, has been used for thousands of years ([@bib19]). CMs prescriptions embody the principles of system theory, and act on multiple cellular targets in multiple pathways to exert therapeutic effects ([@bib7]; [@bib13]). COVID-19 belongs to the category of pestilence or epidemic in CM ([@bib34]). CMs had been used to treat and prevent viral infection pneumonia diseases for thousands of years and had accumulated a large number of clinical experience and effective prescription ([@bib15]). In the "Diagnosis and Treatment Program for Corona Virus Disease 2019 (COVID-19)" issued by the National Health Commission of China, it is recommended to treat with CMs and had achieved good clinical effects. Thus, it is very significant to explore and mine experiences of CMs in treating of pestilence or epidemic diseases based on the abundant historical classics of CMs combined with modern medical research method. In the present study, data mining and association network were used to mine the high-frequency CMs and formulas from ancient prescriptions. Furthermore, molecular docking approach were used to explore binding rates between the main ingredients in high frequency CMs and the key targets of SARS-COV-2. Then, we preliminarily uncover molecular mechanism by a network pharmacology process ([Fig. 1](#fig1){ref-type="fig"} ). These results are expected to provide referenced candidate CMs formulas or active compounds to overcome COVID-19.Fig. 1The whole framework based on an integration strategy of screening system.Fig. 1

2. Material and method {#sec2}
======================

2.1. Data mining {#sec2.1}
----------------

### 2.1.1. Data sources {#sec2.1.1}

In our study, the *Dictionary of Traditional Chinese Medicine Prescriptions* ([@bib17]) and *Pharmacopoeia of the People\'s Republic of China* ([@bib18]) were used to screened the prescriptions containing "Warm diseases (Wenbing)", "Pestilence (Wenyi or Yibing)" or "Epidemic diseases (Shiyi)".

The data processing process included the following three steps: Firstly, the relevant prescriptions retrieved were inputted into the word document to obtain the original literature file; Secondly, key words of prescription information contained number, name, source, formula, efficacy, therapy, dosage form and number of natural medicines and ancient literature classified information were inputted into the Excel file; Finally, prescription data were standardized on the basis of *Pharmacopoeia of the People\'s Republic of China* ([@bib17]) and the *Chinese Materia Medica* ([@bib30]). Then standardized data was imported to database for following data mining and association network analysis.

### 2.1.2. Data analyze and association network analysis {#sec2.1.2}

In our present study, frequency analysis method, association rule mining method and association knowledge network construction method were used to analyze the collected prescriptions. The high frequency CMs were mined by frequency analysis method, and the compatibility rule of prescription was analyzed by association rules. The rules package was called into the formula basket data by R software platform, and the Apriori algorithm was used to mine the data for association rules with Confidence, Support and Promotion as the criteria ([@bib4]). Support value was the percentage of preconditions that were true and used to measure universality; Confidence value was the percentage of preconditions for which records and the conclusions were both true, mainly used for measuring accuracy; Promotion value was used to evaluate the degree to which the appearance of one item set increased the appearance of another ([@bib28]). The mined related knowledge was screened and visualized by the arulesViz package to construct the associated knowledge network ([@bib6]).

2.2. Molecular docking {#sec2.2}
----------------------

### 2.2.1. Screening of active components in CMs {#sec2.2.1}

The chemical composition of high-frequency CMs were obtained from the TcmSP™ (Traditional Chinese Medicine System Pharmacology Database, <http://tcmspw.com/tcmsp.php>). Meanwhile, important pharmacology-related parameters of compounds were also obtained from TcmSP™, including drug-likeness (DL) and oral bioavailability (OB). The compounds with OB \>30% and DL \> 0.18 were selected as candidate compounds for further analysis ([@bib22]). Besides, some compounds with low OB or DL values were also selected for candidate compounds because of their excellent pharmacological activities or high contents ([@bib26]). The sdf format of the main active ingredients' structures were downloaded from PubChem (<https://pubchem.ncbi.nlm.nih.gov/>) as candidates for molecular docking.

### 2.2.2. Preparation of the target proteins and the active site {#sec2.2.2}

The high-resolution crystal structure of COVID-19 3CL hydrolase (Mpro) was obtained from PDB (PDB_ID: 6LU7) ([@bib10]) ([Fig. 2](#fig2){ref-type="fig"} ). The active site of the protein is centered on the active amino acid site of the original ligand in the crystal structure. The corresponding "active pocket" was constructed. The system searched for the "active pocket" near the active site, and finally −8.669631, 12.384467, and 67.029640 with a point count of 8538 were defined as active pocket.Fig. 2High-resolution crystal structure of novel coronavirus target 3CL hydrolase (Mpro) (PDB [6LU7](pdb:6LU7){#intref0035}). The circle in the figure is the position of the active pocket.Fig. 2

The high-resolution crystal structure of angiotensin-converting enzyme 2 (ACE2) was obtained from PDB (PDB_ID:2AJF) ([Fig. 2](#fig2){ref-type="fig"}). The two active sites of the protein are centered on the active amino acid site of the original ligand in the crystal structure. The active site 1 of 15.262085, −17.780927, 57.786474 with the points count of 4198 ([Fig. 3](#fig3){ref-type="fig"} ) and the active site 2 of 21.539614,7.755639,61.035558 with the points count of 4198 ([Fig. 4](#fig4){ref-type="fig"} ) were constructed to dock.Fig. 3High-resolution crystal structure of ACE2(PDB_ID:2AJF) site 1. The circle in the figure is the position of the active pocket.Fig. 3Fig. 4High-resolution crystal structure of ACE2(PDB_ID:2AJF) site 2. The circle in the figure is the position of the active pocket.Fig. 4

### 2.2.3. Molecular docking method {#sec2.2.3}

Receptor-Ligand interaction module in Discovery [@bib21]) R2 were used to explore binding rates between the main ingredients in high frequency CMs and the key targets of SARS-COV-2. The LigandFit molecular docking parameter settings remained the default parameters.

In order to ensure the accuracy of the results, scoring was performed with seven scoring functions: DockScore, LigScore1, LigScore2, PLP1, PLP2, Jain and PMF. Then, consensus score was used to analysis of seven scoring functions selected for Ligandfit docking, which produces a single consensus score value for each ligand rather than for each posed to measure the result. The threshold was set at greater than four.

2.3. Potential action mechanisms of high-frequency CMs pairs {#sec2.3}
------------------------------------------------------------

The Huangqin and Gancao CMs-pair were selected to explore their possible molecular mechanism. The chemical compositions were obtained according to "2.2.1 Screening of active components in CMs". We then predicted the potential targets using target prediction approach developed by [@bib5]. Noteworthy, only the targets with reliability score greater than 0.9 of *Homo sapiens* were retained for further analysis. After, we established the Protein-Protein Interaction (PPI) network for the targets by using String Datasets (<https://string-db.org/>), and the PPI networks were further visualized by using Cytoscape (Version 3.5.0, available at <http://www.cytoscape.org/>) ([@bib21]).

DAVID, a database for annotation, visualization and integrated discovery to identify the functions, was used to perform GO enrichment analysis and KEGG pathway enrichment analyses for the potential targets ([@bib8]). The *P*-value was calculated and further corrected by using the Benjamini-Hochberg method, and *P*-value \<0.05 was selected as the cutoff criterion. Subsequently, the compound-target network, and target-pathway network were constructed and visualized by using Cytoscape (Version 3.5.0).

3. Results and discussion {#sec3}
=========================

3.1. CMs prescriptions screening results {#sec3.1}
----------------------------------------

Chinese medicine prescriptions (fang ji in Chinese) is the main form of CMs application in clinical practice ([@bib20]). *Dictionary of Traditional Chinese Medicine Prescriptions* is the summary of research achievement in CMs prescriptions, which contains more than 1800 kinds of CMs and 90, 000 prescriptions in related literatures ([@bib17]). In our study, the prescriptions for treatment of pestilence or epidemic diseases were mined from *Dictionary of Traditional Chinese Medicine Prescriptions*. 574 prescriptions were selected for the treatment of "Wenbing", "Wenyi", "Yibing" or "Shiyi". The age distribution of prescriptions showed that the use of CMs to prevent epidemics could be traced back to Jin dynasty ([Fig. 5](#fig5){ref-type="fig"} ). The selected prescriptions were mainly distributed in the Song, Ming and Qing dynasties, especially the Qing dynasty with 325 kinds of prescriptions. It was estimated that it may be due to the academic development of Seasonal Febrile Disease after the Ming dynasty. Dr. Wu Youke from Ming dynasty proposed the etiological theory of "liqi" for the first time, which mean the evil epidemic pathogenic factors in *Wen Yi Lun* ([@bib25]). Wu emphasized that Wen diseases (pestilence) was totally different from febrile disease and clearly pointed out that *"The wenyi was a disease, not feng(wind), han(cold), shu(heat) or shi(damp), but a strange feeling between heaven and earth"*. In addition, Wu established the thinking mode of syndrome differentiation and created the effective prescription named "Dayuanyin" for treating pestilence diseases. While during the formation of Seasonal Febrile Disease school in the Qing Dynasty, febrile pathologists such as Ye Gui, Wu Jiao, Wang Shixiong and Xue Shengbai not only put forward the academic opinions of Wei Qi Ying Xue from *Wen Bing Lun* ([@bib27]), Differentiation of Triple Energizer from *Wen Bing Tiao Bian* ([@bib24]). Abundant publishes and excellent prescriptions of Wen diseases were also created in that times.Fig. 5Distribution times of 574 prescriptions for treatment of pestilence or epidemic diseases.Fig. 5

3.2. High frequency CMs from prescriptions {#sec3.2}
------------------------------------------

In order to screen high frequency CMs, we counted the frequency of the herbs used in screened CMs formulae by frequency analysis method. The results showed that 40 kinds of CMs with the highest frequency from above prescriptions ([Table 1](#tbl1){ref-type="table"} , [Table 2](#tbl2){ref-type="table"} ). Glycyrrhizae Radix Et Rhizoma (Gancao; *Glycyrrhiza uralensis* Fisch, Rhizome) was the most frequency used in half of the CM prescriptions, followed by Scutellariae Radix (HuangQin; *Scutellaria baicalensis* Georgi, root) and Rhei Radix Et Rhizome (Dahuang; *Rheum palmatum* L., *Rheum tanguticum* Maxim. ex Balf., or *Rheum officinale* Baill., Rhizome), both of them were used more than 100 times. Most of these high frequency CMs were kinds of cold and heat-clearing CMs, which corresponding to the classic Warm disease\'s symptoms of syndrome differentiation of COVID-19. Among them, *HuangQin* (Scutellariae Radix) could relive lung heat corresponding to the high fever syndrome type of COVID-19, and *Dahuang* (Rhei Radix Et Rhizome) discharging damp-heat of large intestine, corresponding to diarrhea syndrome of some patients of COVID-19. At the same time, there were also some supplementing Qi and nourishing Yin CMs, such as Paeoniae Radix Alba (Baishao; *Paeonia lactiflora* Pall., root), Angelicae Sinensis Radix (Danggui; *Angelica sinensis* (Oliv.) Diels, root), Rehmanniae Radix (Shengdi; *Rehmannia glutinosa* (Gaertn.) DC., root) and Ginseng Radix Et Rhizoma (Renshen; *Panax ginseng* C.A.Mey., Rhizome), and expectorant CMs, such as Citri Reticulatae Pericarpium (Chenpi; *Citrus reticulata* Blanco, fruit) and Platycodonis Radix (Jiegeng; *Platycodon grandiflorus* (Jacq.) A.DC., root). The above results indicated the principle of Traditional Chinese Medicine with strengthening the body resistance to eliminate pathogenic factors and treating both symptom and root au.Table 1The Names of High frequency CMs.Table 1No.Chinese NameLatin name[a](#tbl1fna){ref-type="table-fn"}Source speciesParts used1GancaoGlycyrrhizae Radix Et Rhizoma*Glycyrrhiza uralensis* FischRhizome*Glycyrrhiza inflata* Batalin*Glycyrrhiza glabra* L.2HuangqinScutellariae Radix*Scutellaria baicalensis* GeorgiRoot3DahuangRhei Radix Et Rhizome*Rheum palmatum* L.Rhizome*Rheum tanguticum* Maxim. ex Balf.*Rheum officinale* Baill.4BaishaoPaeoniae Radix Alba*Paeonia lactiflora* Pall.Root5ChenpiCitri Reticulatae Pericarpium*Citrus reticulata* BlancoFruit6ChaihuBupleuri Radix*Bupleurum chinense* DC.Root*Bupleurum scorzonerifolium* Willd.7JiegengPlatycodonis Radix*Platycodon grandiflorus* (Jacq.) A.DC.Root8CangzhuAtractylodes Rhizoma*Atractylodes lancea* (Thunb.) DC.Rhizome*Atractylodes chinensis* (DC.) Koidz.9DangguiAngelicae Sinensis Radix*Angelica sinensis* (Oliv.) DielsRoot10ShengdiRehmanniae Radix*Rehmannia glutinosa* (Gaertn.) DC.Root11ShigaoGypsum FibrosumGypsum12GegenPuerariae Lobatae Radix*Pueraria lobata* (Willd.) OhwiRoot13HoupuMagnolia Officinalis Cortex*Magnolia officinalis* Rehder & E.H.WilsonBark*Magnolia officinalis* var. biloba Rehder & E.H.Wilson14ChuanxiongChuanxiong Rhizoma*Ligusticum chuanxiong* Hort.Root15FangfengSaposhnikoviae Radix*Saposhnikovia divaricata* (Turcz.) Schischk.Root16ShexiangMoschus*Moschus berezovskii* Flerov.Musk bag*Moschus sifanicus* Przewalski*Moschus moschiferus* Linnaeus17HuanglianCoptidis Rhizoma*Coptis chinensis* Franch.Rhizome*Coptis deltoidea* C.Y.Cheng et Hsiao*Coptis teeta* Wall.18QianghuoNotopterygii Rhizoma Et Radix*Notopterygium incisum* K.C.Ting ex H.T.ChangRhizome*Notopterygium franchetii* H.Boissieu19XuanshenScrophulariae Radix*Scrophularia ningpoensis* Hemsl.Root20BaizhiAngelicae Dahuricae Radix*Angelica dahurica* (Hoffm.) Benth. & Hook.f. ex Franch. & Sav.Root21RenshenGinseng Radix Et Rhizoma*Panax ginseng* C.A.Mey.Root22XionghuangRealgarRealgar23FulingPoria*Poria cocos*(Schw.)WolfSclerotium24ZhiqiaoAurantii Fructus*Citrus × aurantium* L.Fruit25MaidongOphiopogonis Radix*Ophiopogon japonicus* (Thunb.) Ker Gawl.Root26JiangcanBombyxbatryticatus*Beauveriaassiana*(Bals.)VuillantSilkworm body27LianqiaoForsythiae Fructus*Forsythia suspensa* (Thunb.) VahlFruit28ZhimuAnemarrhenae Rhizoma*Anemarrhena asphodeloides* BungeRhizome29BanxiaPinelliae Rhizoma*Pinellia ternata* (Thunb.) MakinoRhizome30BoheMenthae Haplocalycis Herba*Mentha haplocalyx* Briq.Stem31ZhushaCinnabarisCinnabar32ShengmaCimicifugae Rhizoma*Cimicifuga heracleifolia* Kom.Rhizome*Cimicifuga dahurica* (Turcz.) Maxim.*Cimicifuga foetida* L.33MahuangEphedra Herba*Ephedra sinica* StapfStem*Ephedra intermedia* Schrenk & C.A.Mey.*Ephedra equisetina* Bunge34ZhiziGardeniae Fructus*Gardenia jasminoides* J.EllisFruit35ChantuiCicadae Periostracum*Cryptotympana pustulata* Fabricius36TianhuafenTrichosanthis Radix*Trichosanthes kirilowii* Maxim.Root*Trichosanthes rosthornii* Harms37ShengjiangZingiber Rhizoma Recens*Zingiber officinale* RoscoeRhizome38XixinAsari Radix Et Rhizoma*Asarum sieboldii* Miq.Rhizome*Asarum heterotropoides* F.Schmidt39HuashiTalcumTalcum40HuoxiangPogostemonis HerbaPogostemon amaranthoides *Benth.*Stem[^2]Table 2High frequency CMs from Prescriptions (top 40).Table 2No.*Pinyin* NameLatin nameFrequencyPercentage, %1GancaoGlycyrrhizae Radix Et Rhizoma29651.572HuangqinScutellariae Radix12321.433DahuangRhei Radix Et Rhizome10317.944BaishaoPaeoniae Radix Alba9716.95ChenpiCitri Reticulatae Pericarpium9115.856ChaihuBupleuri Radix7412.897JiegengPlatycodonis Radix7412.898CangzhuAtractylodes Rhizoma6912.029DangguiAngelicae Sinensis Radix6912.0210ShengdiRehmanniae Radix6912.0211ShigaoGypsum Fibrosum6912.0212GegenPuerariae Lobatae Radix6611.513HoupuMagnolia Officinalis Cortex6511.3214ChuanxiongChuanxiong Rhizoma6310.9815FangfengSaposhnikoviae Radix6210.816ShexiangMoschus6210.817HuanglianCoptidis Rhizoma6110.6318QianghuoNotopterygii Rhizoma Et Radix6010.4519XuanshenScrophulariae Radix5810.120BaizhiAngelicae Dahuricae Radix579.9321RenshenGinseng Radix Et Rhizoma559.5822XionghuangRealgar559.5823FulingPoria549.4124ZhiqiaoAurantii Fructus549.4125MaidongOphiopogonis Radix539.2326JiangcanBombyxbatryticatus529.0627LianqiaoForsythiae Fructus529.0628ZhimuAnemarrhenae Rhizoma529.0629BanxiaPinelliae Rhizoma518.8930BoheMenthae Haplocalycis Herba518.8931ZhushaCinnabaris518.8932ShengmaCimicifugae Rhizoma488.3633MahuangEphedra Herba468.0134ZhiziGardeniae Fructus447.6735ChantuiCicadae Periostracum417.1436TianhuafenTrichosanthis Radix417.1437ShengjiangZingiber Rhizoma Recens406.9738XixinAsari Radix Et Rhizoma406.9739HuashiTalcum386.6240HuoxiangPogostemonis Herba386.62

3.3. High frequency CMs-pair and triple-CMs groups in prescriptions {#sec3.3}
-------------------------------------------------------------------

CMs-pair and triple-CMs groups are the basic forms of compatibility of CMs. There were 36 CMs-pair with a frequency of more than 5% from above prescriptions ([Table 3](#tbl3){ref-type="table"} ). *Gancao* (Glycyrrhizae Radix Et Rhizoma) was most commonly used in high frequency CMs-pair. Most frequently used CMs-pair was *Huangqin* (Scutellariae Radix) and *Gancao* (Glycyrrhizae Radix Et Rhizoma) pair, which was the sovereign drug of Gancao Huangqin Tang in the *Si Sheng Xin Yuan* ([@bib9]). Huangqin is a frequently used CMs, and have the effects of clearing heat and depriving the evil wetness, heat-clearing and detoxicating, while *Gancao* (Glycyrrhizae Radix Et Rhizoma) have the effects of tonifying the middle body and supplementing Qi. *Huangqin* (Scutellariae Radix) and *Gancao* (Glycyrrhizae Radix Et Rhizoma) CMs-pair could be used for treating heat syndrome caused by SARS-COV-2.Table 3High frequency CMs-pair in prescriptions(percentage \>5%).Table 3No.CMs-pairFrequencyPercentage, %1*Huangqin* (Scutellariae Radix) & *Gancao* (Glycyrrhizae Radix Et Rhizoma)8915.482*Baishao* (Paeoniae Radix Alba) & *Gancao* (Glycyrrhizae Radix Et Rhizoma)8013.913*Chenpi* (Citri Reticulatae Pericarpium) & *Gancao* (Glycyrrhizae Radix Et Rhizoma)7412.874*Chaihu* (Bupleuri Radix) & *Gancao* (Glycyrrhizae Radix Et Rhizoma)5910.265*Gegen* (Puerariae Lobatae Radix) & *Gancao* (Glycyrrhizae Radix Et Rhizoma)569.746*Qianghuo* (Notopterygii Rhizoma Et Radix) & *Gancao* (Glycyrrhizae Radix Et Rhizoma)569.747*Chuanxiong* (Chuanxiong Rhizoma) & *Gancao* (Glycyrrhizae Radix Et Rhizoma)559.578*Jiegeng* (Platycodonis Radix) & *Gancao* (Glycyrrhizae Radix Et Rhizoma)559.579*Fangfeng* (Saposhnikoviae Radix) & *Gancao* (Glycyrrhizae Radix Et Rhizoma)518.8710*Zhiqiao* (Aurantii Fructus) & *Gancao* (Glycyrrhizae Radix Et Rhizoma)488.3511*Danggui* (Angelicae Sinensis Radix) & *Gancao* (Glycyrrhizae Radix Et Rhizoma)488.3512*Houpu* (Magnolia Officinalis Cortex) & *Gancao* (Glycyrrhizae Radix Et Rhizoma)478.1713*Cangshu* (Atractylodes Rhizoma) & *Gancao* (Glycyrrhizae Radix Et Rhizoma)447.6514Baizhi (Angelicae Dahuricae Radix) & *Gancao* (Glycyrrhizae Radix Et Rhizoma)437.4815*Shigao* (Gypsum Fibrosum) & *Gancao* (Glycyrrhizae Radix Et Rhizoma)427.316*Fuling* (Poria) & *Gancao* (Glycyrrhizae Radix Et Rhizoma)427.317*Huanglian* (Coptidis Rhizoma) & *Huangqin* (Scutellariae Radix)417.1318*Renshen* (Ginseng Radix Et Rhizoma) & *Gancao* (Glycyrrhizae Radix Et Rhizoma)406.9619*Baizhi* (Angelicae Dahuricae Radix) & *Chuanxiong* (Chuanxiong Rhizoma)396.7820*Zhimu* (Anemarrhenae Rhizoma) & *Gancao* (Glycyrrhizae Radix Et Rhizoma)386.6121*Xuanshen* (Scrophulariae Radix) & *Gancao* (Glycyrrhizae Radix Et Rhizoma)386.6122*Bohe* (Menthae Haplocalycis Herba) & *Gancao* (Glycyrrhizae Radix Et Rhizoma)386.6123*Chuanxiong* (Chuanxiong Rhizoma) & *Qianghuo* (Notopterygii Rhizoma Et Radix)386.6124*Xionghuang* (Realgar) & *Shexiang* (Zingiber Rhizoma Recens)376.4325*Zhizi* (Gardeniae Fructus) & *Huangqin* (Scutellariae Radix)356.0926*Lianqiao*(Forsythiae Fructus) & *Gancao* (Glycyrrhizae Radix Et Rhizoma)356.0927*Banxia* (Pinelliae Rhizoma) & *Gancao* (Glycyrrhizae Radix Et Rhizoma)356.0928*Chantui* (Cicadae Periostracum) & *Jiangcan* (Bombyxbatryticatus)335.7429*Xionghuang* (Realgar) & *Zhusha* (Cinnabaris)335.7430*Zhusha* (Cinnabaris) & *Shexiang* (Moschus)325.5731*Shengma* (Cimicifugae Rhizoma) & *Gancao* (Glycyrrhizae Radix Et Rhizoma)325.5732*Mahuang* (Ephedra Herba) & *Gancao* (Glycyrrhizae Radix Et Rhizoma)315.3933*Tianhuafen* (Trichosanthis Radix) & *Gancao* (Glycyrrhizae Radix Et Rhizoma)315.3934*Bohe* (Menthae Haplocalycis Herba) & *Jiegeng* (Platycodonis Radix)305.2235*Bingpian* (Borneolum) & *Shexiang* (Moschus)295.0436*Huoxiang* (Pogostemonis Herba) & *Gancao* (Glycyrrhizae Radix Et Rhizoma)295.04

As for triple-CMs-groups, Chuanxiong Rhizoma (Chuanxiong; *Ligusticum chuanxiong* Hort.), Notopterygii Rhizoma Et Radix (Qianghuo; *Notopterygium incisum* K.C.Ting ex H.T.Chang, *Notopterygium franchetii* H.Boissieu, root) and *Gancao* (Glycyrrhizae Radix Et Rhizoma) group was used most commonly in the prescription, followed by Bupleuri Radix (Chaihu; *Bupleurum chinense* DC., *Bupleurum scorzonerifolium* Willd., root), *Huangqin* (Scutellariae Radix) and *Gancao* (Glycyrrhizae Radix Et Rhizoma) groups ([Table 4](#tbl4){ref-type="table"} ). The CMs-pair of *Qianghuo* (Notopterygii Rhizoma Et Radix) and *Chuanxiong* (Chuanxiong Rhizoma) had properties of enhancing in compatibility, which was used in Jiuwei Qianghuo Decoction and Da Qianghuo Decoction recorded in *Difficult to Know* ([@bib23]). *Qianghuo* (Notopterygii Rhizoma Et Radix) belongs to Taiyang meridian which performed guiding role in medicine applying; While Chuanxiong was belonged to Jueyin meridian played the role as guiding medicine. The combination of *Qianghuo* (Notopterygii Rhizoma Et Radix) and *Chuanxiong* (Chuanxiong Rhizoma) showed better pharmacological effects in headache therapy originated from the Taiyang and/or Jueyin, and could be helpful for headache syndrome caused by SARS-COV-2.Table 4High frequency Triple-CMs-group in prescriptions(percentage \>5%).Table 4No.Triple-CMs-groupFrequencyPercentage, %1*Chuanxiong* (Chuanxiong Rhizoma) & *Qianghuo* (Notopterygii Rhizoma Et Radix) & *Gancao* (Glycyrrhizae Radix Et Rhizoma)386.612*Chaihu* (Bupleuri Radix) & *Huangqin* (Scutellariae Radix) & *Gancao* (Glycyrrhizae Radix Et Rhizoma)376.433*Baizhi* (Angelicae Dahuricae Radix) & *Gancao* (Glycyrrhizae Radix Et Rhizoma) & *Chuanxiong* (Chuanxiong Rhizoma)325.574*Fangfeng* (Saposhnikoviae Radix) & *Gancao* (Glycyrrhizae Radix Et Rhizoma) & *Qianghuo* (Notopterygii Rhizoma Et Radix)325.575*Chaihu* (Bupleuri Radix) & *Qianghuo* (Notopterygii Rhizoma Et Radix) & *Gancao* (Glycyrrhizae Radix Et Rhizoma)325.576*Chuanxiong* (Chuanxiong Rhizoma) & *Fangfeng* (Saposhnikoviae Radix) & *Gancao* (Glycyrrhizae Radix Et Rhizoma)295.04

3.4. Analysis of association rules and network of compatibility in CM prescriptions {#sec3.4}
-----------------------------------------------------------------------------------

Association rule mining is often used to find possible associations or connections between substance, and it has been applied to study the compatibility of CMs prescriptions ([@bib31]). We mined the association relationship ([Supplementary Table S1](#appsec1){ref-type="sec"}) and matrix analysis ([Fig. 6](#fig6){ref-type="fig"} ) for the compatibility relationship of CMs and built the association knowledge network of CMs ([Fig. 6](#fig6){ref-type="fig"}). From these results, *Gancao* (Glycyrrhizae Radix Et Rhizoma) and *HuangQin* (Scutellariae Radix) were key medicines of these prescriptions for treatment of pestilence or epidemic diseases. Most of the CM prescriptions were designed basing on these two CMs.Fig. 6CMs incidence matrix of prescription (A) and CMs association network of prescription (B).Fig. 6

3.5. LigandFit DOCK results of ingredients from high frequency CMs with SARS-COV-2 targets {#sec3.5}
------------------------------------------------------------------------------------------

The chemical composition of high frequency CMs were obtained from the Traditional Chinese Medicine System Pharmacology Database. There are 40 kinds of high-frequency CMs, five of which are not included in the database. Although a single CM usually contains a large number ingredient, only those with desirable pharmacodynamic and pharmacokinetic properties are key compounds for their therapeutic effects. In our current study, OB and DL were employed to screen candidate compounds from these high frequency CMs. In total, 35 high-frequency CMs includes 431 chemicals, which were molecularly docked with the SARS-COV-2 targets 3CL hydrolase and angiotensin converting enzyme 2 (ACE2) using LigandFit.

Consensus scoring, the combination of multiple scoring functions, is easier to find false positive than a single scoring function. The higher the Consensus scoring, the higher the binding rate of the molecule to the target. The score is greater than 4, indicating a better docking result. In our study, compounds with scoring values greater than 4 were screened for analysis. Therefore, 66 compounds were screened, of which 27 were docked with the 3CL hydrolase target and 48 were docked with the ACE2 target. The screened compounds were distributed in 27 kinds of CMs, among which *Gancao* (Glycyrrhizae Radix Et Rhizoma), *HuangQin* (Scutellariae Radix), *Dahuang* (Rhei Radix Et Rhizome) and *Chaihu* (Bupleuri Radix) contain more potential compounds ([Fig. 7](#fig7){ref-type="fig"} , [Supplementary Table S2](#appsec1){ref-type="sec"}). The results of molecular docking were consistent with the frequency results of high frequency CMs.Fig. 7High Frequency CMs with active components distribution.Fig. 7

3C-like protease (3CL^Pro^) play an important role in the replication of the virus, which is considered to be an attractive target for drug development ([@bib12]). Acetoside (Consensus scoring = 7) has the strongest binding activity to 3CL hydrolase, which comes from *Shengdi* (Rehmanniae Radix). In Acetoside, hydrogen bonds were formed between phenolic hydroxyl groups and residues THR and PHE, and hydrophobic interaction was formed between benzene ring and target protein GLU ([Fig. 8](#fig8){ref-type="fig"} A). In addition, various components in high frequency CMs, such as *Gancao* (Glycyrrhizae Radix Et Rhizoma), *Dahuang* (Rhei Radix Et Rhizome) and *Chaihu* (Bupleuri Radix), also have potential anti-activity on 3CL protein ([Supplementary Table S2](#appsec1){ref-type="sec"}).Fig. 8Molecular docking patterns of candidate compounds with SARS-COV-2 targets. A: Acetoside with 3CL; B: Glyasperin F with ACE2 stie 1; C: Isorhamnetin with ACE2 site 2.Fig. 8

According to the two binding regions grid3 and grid4 between ACE2 and viral protein conformation ([@bib16]), components which may block the binding of the two proteins were screened. Glyasperin F in *Gancao* (Glycyrrhizae Radix Et Rhizoma) had the strongest binding to site ACE 1(Consensus scoring = 6), and hydrogen bond and σ-p hyperconjugated system was formed between its phenolic hydroxyl group forms and target protein residue LEU ([Fig. 8](#fig8){ref-type="fig"}B). Isorhamnetin in *Gancao* (Glycyrrhizae Radix Et Rhizoma) and *Chaihu* (Bupleuri Radix) has the strongest binding ability to ACE site 2 (Consensus scoring = 6), which mainly formed hydrophobic interaction between benzene ring and residue target protein residue PRO ([Fig. 8](#fig8){ref-type="fig"}C). Besides, various ingredient in CMs, such as *HuangQin* (Scutellariae Radix), *Chaihu* (Bupleuri Radix) and *Zhimu*(Anemarrhenae Rhizoma), could combined with ACE2 protein.

3.6. Systemic pharmacological analysis of high-frequency CMs pairs {#sec3.6}
------------------------------------------------------------------

According to the frequency analysis, association rule analysis and molecular docking results of high-frequency CMs, *Gancao* (Glycyrrhizae Radix Et Rhizoma) and *HuangQin* (Scutellariae Radix) were the key medicines pairs of these prescriptions for treatment of COVID-19. A systemic pharmacology model based on chemical, pharmacokinetic and pharmacological data was constructed to explore the molecular mechanisms.

In the present work, the number of 85 and 34 kinds of active compounds were selected from *Gancao* (Glycyrrhizae Radix Et Rhizoma) and *HuangQin* (Scutellariae Radix), respectively. The detailed information about those molecules were provided in [Supplementary Table S3](#appsec1){ref-type="sec"}. An integrated *in silico* approach was introduced to identify the target proteins for the active compounds of CMs ([@bib5]). We totally obtained 286 potential therapeutic targets for 119 kinds of candidate compounds from *Gancao* (Glycyrrhizae Radix Et Rhizoma) and *HuangQin* (Scutellariae Radix). Then, we constructed a PPI (335 nodes and 4237edges) network for the putative targets of the compounds. Based on the average values for degree and distance of 21 and 2.3, respectively, we have identified 30 significant targets from *Gancao* (Glycyrrhizae Radix Et Rhizoma) and *HuangQin* (Scutellariae Radix) ([Fig. 9](#fig9){ref-type="fig"} A, [Supplementary Table S4](#appsec1){ref-type="sec"}). In order to directly represent the interpretation of the complex relationships between active compounds and their targets, C-T network was constructed ([Fig. 9](#fig9){ref-type="fig"}B). Amongst them, those ones with high interconnection degrees were responsible for the high interconnectedness of the C-T network, especially Quercetin (degree = 10), 5,7,2′,6′-Tetrahydroxyflavone (degree = 12), Kaempferol (degree = 12), 4′-Hydroxywogonin (degree = 11), Ganhuangenin (degree = 11), Baicalein (degree = 9), Gancaonin O (degree = 8), and Norwogonin (degree = 8). As shown in the C-T network ([Fig. 9](#fig9){ref-type="fig"}B), a compound regulated multiple targets, while multiple compounds possibly regulate the same target.Fig. 9Potential action mechanisms of *Gancao* (Glycyrrhizae Radix Et Rhizoma) and *HuangQin* (Scutellariae Radix) CMs-pair. A: PPI network of candidate Gancao-Huangqin CMs-pair targets; B: Construction of the Gancao-Huangqin CMs-pair compound-target network. The nodes representing candidate compounds are shown as red, and the targets are indicated as green; C:Construction of the Gancao-Huangqin CMs-pair target-pathway network; D: Pathway enrichment analysis of candidate targets. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)Fig. 9

The significant targets interacting with the active ingredients were mapped onto the KEGG pathways and the T-P network was generated as shown in [Fig. 9](#fig9){ref-type="fig"}C. Among the results of KEGG pathway enrichment, we selected the pathways in the basic biological processes of metabolism, genetic information processing, environmental information processing, cellular processes and organismal system. There are 20 target-enriched pathways ([Table 5](#tbl5){ref-type="table"} ), which act on the immune system, inflammation, cellular processes, and endocrine system, respectively. Thus, we postulated that *Gancao* (Glycyrrhizae Radix Et Rhizoma) and *HuangQin* (Scutellariae Radix) CM pair exerts therapeutic effects on multiple targets and pathways of the human body through hits complex active component.Table 5KEGG pathways regulated by *Gancao* (Glycyrrhizae Radix Et Rhizoma) and *HuangQin* (Scutellariae Radix) CMs-pair target.Table 5Pathway classificationPathwayCount*P*-ValueImmune stystemNOD-like receptor signaling pathway77.26E-08T cell receptor signaling pathway72.36E-06Toll-like receptor signaling pathway65.86E-05InflammationPI3K-Akt signaling pathway124.29E-08TNF signaling pathway66.13E-05Chemokine signaling pathway78.27E-05AngiogenesisVEGF signaling pathway59.77E-05NervousNeurotrophin signaling pathway60.000106ErbB signaling pathway62.25E-05Cellular processesAdherens junction68.3E-06Cell cycle84.51E-07Sphingolipid signaling pathway60.000106p53 signaling pathway50.000141HIF-1 signaling pathway92.65E-09FoxO signaling pathway93.77E-08Central carbon metabolism in cancer64.96E-06Endocrine systemThyroid hormone signaling pathway111.17E-11Estrogen signaling pathway89.55E-08Progesterone-mediated oocyte maturation71.04E-06Prolactin signaling pathway89.2E-09

Under the guidance of the theory of "treating non-disease" in TCM, CMs and CM prescriptions play a multi-effect synergistic effect, which makes them have more significant advantages in anti-COVID-19 ([@bib14]). The classical CM prescriptions condense the experience in fighting against epidemics diseases for thousands of years. Its successful effects have been preliminarily confirmed in clinical studies when applied to SARS and H1N1 influenza epidemics ([@bib32],[@bib33]). Meanwhile, Qing-Fei-Pai-Du decoction is a CM prescription recommended by the National Health Commission of China for the treatment of COVID-19, which was optimized by combination of a number of classical prescriptions from *Treatise on Febrile and Miscellaneous* (Han dynasty) ([@bib29]). Thus, the experiences and effective prescriptions of CM in treating and preventing viral infection diseases for thousands of years is worthwhile to explore and are of great significance and reasonable.

We excavated 574 CM prescriptions for treating epidemic diseases through 96, 606 prescription. Among them, 40 kinds of high frequency CMs, 36 high-frequency CMs-pairs and 6 kinds of high-frequency triple-CM-groups were mined by frequency analysis method were used to analyze the collected prescriptions. Among the commonly used CMs beneficial for antiviral, *Gancao* (Glycyrrhizae Radix Et Rhizoma) and *HuangQin* (Scutellariae Radix) were given high priority CM pairs for selection used in CM prescriptions against pestilence by mining the compatibility rules of prescriptions with association rules analyses. The molecular docking results implied that 66 compounds in 26 kinds of CMs probably show a potential anti-SARS-COV-2 activity by binding with the ACE2 and 3CL hydrolase. It\'s worth noting that *Gancao* (Glycyrrhizae Radix Et Rhizoma) contained the most potential compounds of 20, followed by *HuangQin* (Scutellariae Radix). Meanwhile, based on network-based computational methods, an integrated system pharmacology approach was used to predict targets, construct networks, and explore the molecular action of high-frequency *Gancao* (Glycyrrhizae Radix Et Rhizoma) and *HuangQin* (Scutellariae Radix) (GH) CMs-pair. In present study, 85 and 34 kinds of active ingredients with favorable bioactivities and contents were selected from *Gancao* (Glycyrrhizae Radix Et Rhizoma) and *HuangQin* (Scutellariae Radix) by ADME filtering, providing some foundational clues for thorough investigation on this CMs-pair. By analyzing the network topology of targets, 30 kinds of important targets were identified. By using network systematic analysis, GH CMs-pair could regulate the proteins related to immune system, inflammation, cellular processes, and endocrine system. COVID-19 leads to a strong immune response and inflammatory storm, in which a large number of cytokines are activated. GH CMs-pair may regulate the immune-related pathway Toll-like receptor signaling pathway, T-cell and B-cell receptor signaling pathway, as well as cytokine action related pathways such as TNF signaling pathway, NF-κB signaling pathway and PI3K-Akt signaling pathway signaling pathway to inhibit the activated cytokines, relieve the excessive immune response and eliminate inflammation. From perspective of molecular network, GH CMs-pair exerted overall regulation through multi-ingredient and multi-target synergistic effect.

4. Conclusion {#sec4}
=============

In conclusion, based on experience of ancient prescription and modern pharmacy research methods, 40 kinds of high frequency CMs, 36 high-frequency CMs-pair and 6 kinds of high-frequency triple-CMs-group were excavated. In addition, the molecular mechanism of the selected key CMs drug pair was preliminarily discussed. *Gancao* (Glycyrrhizae Radix Et Rhizoma) and *HuangQin* (Scutellariae Radix) CMs-pair with highest frequency show a potential anti-SARS-COV-2 activity by binding with the ACE2 and 3CL hydrolase and regulate the target related to immune system, inflammation, cellular processes, and endocrine system. Our results provide referenced candidate compatibility of CM and active ingredients against SARS-COV-2. The results fully reflected the synergistic mechanism of multi-components and multi-targets of CMs. In view of the limitations of virtual screening results, further experiments *in vivo* and *in vitro* are needed to verify the results of this study in the later stage, so as to provide experimental basis for the research and development of antiviral natural drugs.
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